In this edition, fludarabine has been placed on the FDA’s drug shortage list; epcoritamab is approved for advanced lymphoma; pembrolizumab with chemotherapy improves OS in gastric cancer, and more.
Read the full coverage here:
Fludarabine shortage requires flexibility, alternative approaches for CAR-T and HSCT
FDA grants priority review to epcoritamab for advanced lymphoma
Pembrolizumab regimen extends OS in metastatic gastric, gastroesophageal junction cancers
New endocrine therapy options for patients with breast cancer on the horizon, expert says
Treatment sequencing key as options increase for patients with urothelial cancer
References:
Petrylak DP. Sequencing therapy throughout the urothelial treatment continuum. Presented at: 40th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow; Nov. 9-11, 2022.
